1 Arginine methylation, catalyzed by various protein arginine 2 methyltransferases (PRMTs), is increasingly recognized as a widespread 3 post-translational modification in eukaryotes. Thousands of proteins undergo 4 arginine methylation, however, a full picture of the catalytic network for each 5 PRMT is lacking, limiting the global understanding of their biological roles. In 6 this study, we reported a systematic identification of interacting proteins for all 7 human PRMTs, and the resulting interactomes are significantly overlapped 8 with the known proteins containing methylarginine. The conserved motifs for 9 arginine methylation by each PRMT were further determined, with several 10 novel motifs being validated. Among different PRMTs, we found a high degree 11 of overlap in their substrates and high similarities between their putative 12 methylation motifs, suggesting possible functional complementation. We 13 demonstrated that arginine methylation is significantly enriched in RNA binding 14 proteins involved in regulating RNA splicing and translation. Consistently, 15 inhibition of PRMTs leads to global alteration of alternative splicing and 16 suppression of translation. In particular, the ribosomal proteins are pervasively 17 modified with methylarginine, and the mutations on methylation sites inhibit 18 ribosome assembly and translation. Collectively, this study provides a global 19 network of different PRMTs and putative substrates, revealing critical functions 20 of arginine methylation in the regulation of mRNA splicing and translation. 21 22 3
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PRMT interactors are significantly enriched for RNA binding proteins involved 2 in mRNA splicing and translation, and inhibition of PRMTs leads to global 3 alteration of alternative splicing and reduction of mRNA translation. We also 4 found that the mutations on methylation site of ribosomal proteins inhibited 5 ribosome assembly. Collectively, this study provides new insight into biological 6 functions of PRMTs and links each PRMT and arginine methylation events in a 7 systematic manner, revealing critical functions of arginine methylation in 8 regulation of RNA metabolism. 2 As catalytic enzymes, the interaction between PRMTs and their 3 substrates are usually dynamic, making it difficult to identify the interacting 4 partners. To systematically characterize interactome of different PRMTs in vivo, 5 we applied the highly sensitive BioID technology to label interacting proteins 6 with biotin. Based on previous reports that N-terminus of PRMT is responsible (BirA R118G ) to the C-terminus of each PRMT and expressed the fusion proteins 10 in HEK293T cells. Biotinylated proteins were subsequently purified with 11 streptavidin beads followed by mass spectrometry analysis ( Fig. 1B, and   12 experimental procedures). As expected, many purified proteins are indeed 13 biotinylated as judged by western blot (Fig. 1C, left) , with the PRMTs 14 themselves being the most heavily biotinylated proteins (Fig. 1C, right) . 15 In total, we have identified 1657 candidate proteins bound by at least one 16 of the nine PRMTs (Table S1 and Fig. S1A ), a lot of which overlapped with the 17 proteins identified in the earlier proteomic studies using immunoprecipitation 18 with antibodies against methylarginine-containing oligopeptides (Guo et al. 19 2014; Larsen et al. 2016) ( Fig. 1D ), indicating the BioID technology is reliable 20 and sensitive in identifying PRMT interactors. 4 5 In addition to the methylation substrates, the interactome of PRMTs may 6 also include proteins that regulate PRMT functions, which could not be 7 identified by immunoprecipitation with methylarginine antibodies. For example, 8 PRMT5 exerts arginine methyltransferase function in the form of a complex 9 with MEP50 (WDR77) (Saha et al. 2016 ), a co-factor that was also identified in 10 the PRMT5 interactome by our experiments. Importantly, only 4% of newly 11 identified PRMT interacting proteins (70 out of 1657 proteins) have been 12 collected in the IntAct online PPI database (https://www.ebi.ac.uk/intact/), 13 suggesting that our results significantly expanded the interactome of each 14 PRMT ( Fig. S1B ). 15 16 Substrate preference of individual PRMTs 17 To further determine the substrate preference of the putative substrates for 18 different PRMTs, we compared the newly identified putative substrates for 19 each PRMT. Our results indicated that many proteins are recognized by 20 multiple PRMTs, suggesting a great deal of substrate redundancy for each 21 PRMT ( Fig. S1C ). For example, RPS3 can be recognized by all 9 PRMTs as 22 judged by our results, and 372 proteins can be recognized by at least 3 out of 9 23 PRMTs tested ( Fig. S1D ). We further examined the overlaps of the interacting 24 10 proteins between each PRMT (Fig. 1E ), and found that the PRMTs can be 1 roughly clustered into two groups based on the similarity of their interactomes. 2 Interestingly, such classification reflects the differences in the dimethylation 3 step of PRMT-catalyzed reactions, with the type II PRMTs (PRMT5 and 4 PRMT9) that catalyze symmetric arginine dimethylation being separated from 5 the other PRMTs that either catalyze asymmetric arginine dimethylation (type I) 6 or does not catalyze dimethylation (PRMT7, type III). 7 8 Identification and validation of consensus motifs for arginine 9 methylation 10 Previous studies have reported that the glycine and arginine rich (GR-rich) 11 motifs are preferably targeted for methylation by many PRMTs (including 12 PRMT1, PRMT3, PRMT5, PRMT6, and PRMT8) (Bedford and Clarke 2009; 13 Thandapani et al. 2013; Blanc and Richard 2017). However, additional 14 consensus motifs such as proline/glycine/methionine rich (PGM-rich) or RxR 15 motifs were also found to be enriched near the methylarginine sites by mass 16 spectrometry (Cheng et al. 2007; Feng et al. 2013 ), suggesting that other 17 sequences beside GR-rich motifs may also be recognized as arginine 18 methylation sites and that individual PRMTs may have different preferences of 19 their substrate. pattern of two representative peptides in SR-rich and PR-rich motifs as detected by mass spectrum. In 5 each case, the upper spectrum indicates the negative control without adding enzymes, and the lower 6 spectrum shows the methylarginine signals after in vitro methylation. For each peptide, the ratio of 7 methylation was calculated as the sum of the peak areas from the TIC values of the modified peptides 8 divided by the peak area of the total peptides. The methylarginines were labeled in red font.
Identification of the interacting proteins of each PRMT
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To further determine the substrate preference for different enzymes, we 11 analyzed the newly identified putative PRMT substrates by measuring the 12 statistic enrichment of the sequences around the potential methylarginine ( Fig.   13 2A, see methods for details). For each PRMT, the tetrapeptides around the 14 potential methylarginine sites were compared with the arginine-containing 15 tetrapeptides in all proteins from UniProt database to calculate the enrichment 16 Z-scores ( Fig. 2A ). The enriched tetrapeptides were further clustered into 17 different groups to obtain consensus motifs for arginine methylation by each 18 PRMT. As an example, the clusters and the consensus motifs for PRMT4 19 substrates were shown in Fig. 2B and the clusters of all PRMTs were shown in 20 supplementary figure S2. We further compared the consensus motifs of all 21 tested PRMTs (Fig. 2C ), and found that in addition to the known RGG motifs 22 from the substrates of many PRMTs, several other new consensus motifs like 23 SR-rich, PR-rich, DR-rich, and ER-rich motifs were also be identified in PRMT 24 substrates. These results provided a comprehensive profile for the substrate 25 preference of different PRMTs, suggesting that a diverse range of proteins 26 could be potentially modified by PRMTs at different consensus motifs. 27 13 In order to validate these newly identified arginine methylation motifs, we 1 selectively synthesized several peptides containing newly identified consensus 2 motifs to measure methylation of arginine by the cognate PRMTs using in vitro 3 methylation reaction (Fig. 2D ). The peptides were incubated with purified 4 PRMTs ( Fig. S3A and S3B ) in the presence of methyl donor 5 S-adenosylmethionine, and resulting samples were analyzed with mass 6 spectrometry. As a positive control, the GR-rich motifs known to be heavily 7 methylated were confirmed in our in vitro methylation assay (not shown). In 8 addition, we found that the arginine residues within the SR-rich, PR-rich, and 9 DR-rich motifs can be robustly methylated by different PRMTs, with both 10 methylation and dimethylation being detected ( Fig. 2E, Fig. S3C ), indicating 11 that these newly identified consensus motifs can indeed be methylated at the 12 arginine sites. 13 14 Potential functions of PRMT substrates 15 To examine the functional consequence of arginine methylation, we 16 inferred the potential functions of the newly identified substrates using gene In order to increase the specificity of our analysis 19 and reduce the statistic noises from the large number of potential substrates, 20 we first focused on the proteins that were identified in both our dataset and to be the regulator of PRMTs rather than their substrates (e.g. WDR77), and 11 these proteins are enriched for RNA-unrelated functions, such as cell division 12 and cell-cell adhesion (Fig. 3A , right). 13 We further examined protein-protein interactions among the potential 14 substrates of each PRMT using STRING database, and found that the two 15 largest and most densely connected clusters primarily consisted of proteins 16 involved in RNA splicing and translation, including a large number of ribosomal 17 proteins and splicing factors ( Fig. 3B ). Although the potential substrates of ). In addition, we found that the core ribosomal proteins and the splicing 21 factors identified in our study generally have a significantly higher frequency of 22 15 arginine in their amino acid composition as compared to all human proteins 1 (Fig. 3C ), further supporting the prevalent methylarginine modification 2 observed in these proteins. Wilcoxon test was used to calculate the p-value. 10 
11
PRMT inhibitions generally altered alternative splicing of RNA 12 The majority of human genes undergo alternative splicing (AS) that is 13 generally regulated by various RNA-binding proteins (i.e., splicing factors) that 14 recognize regulatory cis-elements to promote or suppress the use of adjacent 15 splice sites (Matera and Wang 2014). It was previously reported that some 16 PRMTs (e.g., PRMT4 and PRMT5) can affect splicing by modifying selected 17 splicing factors or proteins involved in spliceosome maturation (Cheng et al. splicing regulation were identified as PRMT substrates ( Fig. 3B and Fig. S4 ), 20 we further examined the effect of PRMT inhibition on alternative RNA splicing. 21 We achieved effective gene silence with shRNAs in six different PRMTs ( 14 18 We found that inhibition of different PRMTs caused significant changes of promoted by inhibition of all six PRMTs tested (Fig. 4E) , and many other genes 13 have undergone alteration of splicing in the same direction ( Fig. S5B ), 14 supporting the consistent regulation of splicing by different PRMTs. 15 16 Ribosomal proteins are pervasively arginine methylated 17 According to the gene ontology and protein-protein interaction analyses, 18 proteins involved in mRNA translation are significantly enriched in the newly 19 identified PRMT substrates, including >72% core components of ribosomes 20 (58 out of 80 ribosome proteins) and many canonical translation factors (such 21 as EIF4G1, EIF4B, EIF2A, etc,). In proteins, suggesting that this type of PTM plays critical roles in protein 10 translation.
To directly test this hypothesis, we performed polysome profiling to isolate 12 different ribosome fractions (the 40S, 60S, 80S, and polysome, Fig. 5A ) and 13 detect their methylation status by pan-arginine methylation antibodies ( Fig. 5B ).
14 Our data demonstrated that ribosomal proteins (most having a MW range of 15 10-50 kD) are pervasively R-methylated in different ribosome profiling fractions 16 ( Fig. 5B ). We also found that PRMTs were not co-purified with ribosomes 17 (Fig 5A) , suggesting that the methylation of ribosomal proteins occurs before 18 ribosome assembly, which is consistent with the absence of PRMTs from the 19 known ribo-interactome (Simsek et al. 2017 ). In addition, we used different 20 types of methylarginine antibodies (MMA, aDMA and sDMA antibodies) to 21 precipitate proteins containing methylarginine and detected many ribosomal 22 20 proteins in the immunoprecipitated samples ( Fig. 5C ), further supporting our 1 conclusion that ribosome proteins are pervasively methylated at arginine 2 residues. hypothesis, we used puromycin incorporation assay to test global protein 7 synthesis in three different types of cells after treatment by the PRMT specific 8 inhibitors ( Fig. 6A, Fig. S6A and S6B for cell lines HEK 293, HCT116 and 9 U2OS, respectively). We used chemical inhibitors of PRMTs because they 10 could provide a more rapid suppression of ribosomal activity that might 11 otherwise be compensated in cells with stable knockdown of PRMTs. 12 We found that the inhibitors of PRMT1 and PRMT4/CARM1 effectively 13 reduced arginine methylation and global protein synthesis across multiple cell 14 lines ( Fig. 6A and Fig. S6 ), and the inhibition of these two PRMTs produced 15 the most obvious reduction in arginine methylation. Therefore, we selected 16 PRMT1 and PRMT4 for further analyses of how PRMT activities affect 17 translation. Using polysome profiling, we found that the inhibition of PRMT1 or 18 PRMT4 effectively reduced the abundances of polysomes vs. monosomes ( Fig.   19 6B), suggesting a global reduction of mRNAs undergoing active translation. Flag-RPS2 (6RA) was transfected into HEK293T cells for 24hr, followed by polysome profiling. Fractions
were collected and used for western blotting with anti-Flag, anti-RPS6 and anti-RPL4 antibodies as 12 indicated.
14
To further examine the potential mechanisms of how arginine methylation 15 affects mRNA translation, we selected the ribosomal protein RPS2, a newly 16 23 identified PRMT1 and PRMT4 substrate in our dataset, for more detailed study.
1
RPS2 has an N-terminal GR-rich motif that is the consensus motif for efficient 2 arginine methylation. We made mutations on the potential methylarginine 3 sites (6RA, with 6 Arg to Ala substitution, see table S2) to examine if such 4 mutations can affect the assembly of RPS2 into ribosome. Using polysome 5 profiling followed by western blotting, we found that the cells transfected with 6 Flag-tagged wide-type PRS2 can efficiently assemble Flag-RPS2 into 7 ribosomes (in fractions of small subunit, monosome and polysomes), however 8 the RPS2 with mutated methylarginine sites are completely depleted from all 9 ribosomal fractions ( Fig. 6C) . Consistently, the deletion of the N-terminal 10 GR-rich motif in RPS2 also cause depletion of PRS2 from the assembled 11 ribosomes, suggest the arginine methylation in this region is critical for the 12 assembly of this protein into ribosomes (Fig. S7 ). 13 14 Inhibition of PRMT activity cause global translation deficiency 15 To further examine how PRMT inhibitions affect the translation of different 16 mRNAs, we sequenced the mRNA population associated with different 17 ribosomal fractions after treatment of PRMT1 and PRMT4 inhibitors (Fig. 7A) . 18 Compared to the control samples treated with DSMO, the inhibition of PRMTs 19 can significantly reduce the level of mRNAs bound by single ribosomes or 20 polysomes (Fig. 7B ). More specifically, among the 6783 protein-coding genes 21 detected with reliable numbers of RNA-seq reads, 4392 mRNAs in the 22 PRMT1-inhibited sample (~65%) and 3830 mRNAs in the PRMT4-inhibited 1 sample (~56%) showed a consistent decrease in the association with different 2 ribosomal fractions (i.e.,both monosome and polysomes), suggesting a 3 general reduction of translation efficiency on most mRNAs (Fig. 7C ). 4 Interestingly, the GO analysis of these mRNAs failed to produce any functional 5 enrichment (not shown), again suggesting a global reduction of mRNA 6 translation rather than translation inhibition on a specific subgroup of mRNAs. 7 We next determined how PRMT inhibition affects translation of different 8 mRNAs using Ribo-seq to measure the distribution of ribosome protected RNA 9 fragments in control and PRMT inhibition samples (Fig. 7D ). This analysis 10 can generate a "snapshot" of all mRNAs that are occupied by active ribosomes 11 (i.e., undergoing active translation) in a cell at a particular condition (Ingolia 12 2016). As expected, the ribosome occupancy is higher in the coding region 13 compared to the 5' and 3' UTRs upon normalized against average coverage 14 (Fig. 7E ). In addition, the binding of ribosomes on mRNA was slightly 15 enriched in the region around the start codon and before the stop codon, 16 suggesting a ribosome pausing after the initiation and the delayed ribosome 17 release ( Fig. 7E ), which is also consistent with the ribosomal profiling results 18 from other groups (reviewed in (Ingolia 2016)). Interestingly, we found that 19 the inhibition of PRMT activity did not change the distribution of ribosome 20 occupancy on different regions of mRNAs (Fig. 7E) . Given the observation of 21 translation reduction by PRMT inhibitions (Fig. 6A and 6B ), this result again 22 25 suggested that PRMTs may affect the maturation of ribosomes before they are 1 assembled onto the mRNAs, consistent with our finding that arginine 2 methylation of ribosomal proteins is essential for ribosome assembly. 
18
We further determined the specific genes whose translation efficiency (TE) 19 was preferably affected by PRMT inhibition by using Xtail pipeline (Xiao et al. 20 2016) to measure the genes with significant TE change after PRMT inhibition 21 (Fig. 7F ). We found that the inhibition of PRMT1 significantly changed the TE 22 of only eight coding genes, whereas the TE of 46 protein-coding genes was 23 significantly altered upon inhibition of PRMT4 (Fig. 7F) . Interestingly, among 24 the 46 genes affected by PRMT4 inhibition, 25 ribosomal protein genes have 25 significantly increased TE, suggesting a potential functional complementation 26 after the translation suppression. a foundation for further studies on their biological functions. 13 One interesting observation is that the majority of the consensus motifs for 14 arginine methylation are short fragments with low sequence complexity, 15 including the well known GR-rich motifs and newly identified SR-and PR-rich 16 motifs ( Fig. 2 and Fig. S2 ). Since low complexity domains (e.g., GR and 17 SR-rich domain in RNA binding proteins) usually form a non-structural region, 18 the recognition by PRMTs likely happens in the unstructured regions of 19 proteins, suggesting a structure independent recognition, which is supportive 20 to the promiscuous binding between PRMTs and many of their targets. This , and thus we expect that the methylarginine 16 modification status of ribosomal proteins is a major source for ribosome 17 heterogeneity. Here we proved that mutations on methylation sites of RPS2 18 can inhibit its assembly into ribosomes, and found that inhibitions of certain 19 PRMTs impose a global suppression on translation. Rather than affecting a 20 specific step of translation, our data implied that the translation reduction may 21 be caused by the defects of ribosome biogenesis before they are assembled 22 29 onto mRNA. 1 Although the ribosomal proteins are significantly enriched with arginine 2 residue and are the most overrepresented targets of PRMTs, we speculate 3 that they are differentially modified by different PRMTs. As a result, inhibition 4 of different PRMTs affected the translation efficiency of distinct sets of mRNAs. 5 More detailed analyses on how each PRMT differentially affects the assembly 6 and functions of ribosomes will be an important subject for future studies. 7 Like many PTM, methylation of arginine also has the specific "readers", 8 "erasers" and "readers". Although nine PRMTs were identified as 9 methylarginine writer, so far there is only one "eraser protein", JMJD6, was the networks consisting of different "writers", "erasers", "readers" and their 15 substrates. Therefore, mapping such interacting network will provide useful 16 information on the function of arginine methylation in various proteins. This 17 study represents a start point for a comprehensive mapping of a network 18 containing methylarginine "writers", "erasers", "readers" and their substrates, 19 and thus may serve as a foundation and reference for future research on this 20 topic. Antibodies: Detailed information for antibodies applied in this study is 4 listed in Table S3 . 5 Cell lines: HEK293T, HCT116 and U2OS cells were cultured according to 6 instructions of American Type Culture Collection (ATCC). The cell lines have 7 been authenticated in GENEWIZ and has been tested to have no mycoplasma 8 contamination by mycoplasma contamination test kit (C0296, Beyotime).
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Tools: software, databases and services were available in supplemental 10 methods. the reversed sequences of all the proteins was appended to the target 11 database to accurately estimate peptide probabilities and false discovery rate 12 (FDR), and FDR was set at 0.01. 13 14 Motif enrichment analysis 15 We retrieved the full sequences of all identified interactors of each PRMT 16 from the UniProt database. We counted all tetrapeptide with arginine amino database. The enrichment score of each tetrapeptide was calculated as Z 21 score based on published methods (Fairbrother et al. 2002) . We collected all 22 motifs with enrichment score larger than 4 and motif number larger than 6 as 1 an input of clustalw2 (v2.0.9) to generate a phylogenetic tree, then clustered 2 these motifs based on branch length and modified manually to ensure the 3 similar motifs in one class. Finally, we used Weblogo3 (WebLogo: A sequence 4 logo generator) to draw the consensus sequence of each cluster. 5 6 In vitro methylation and MS detection of arginine methylated peptides 7 The HEK293T cells transiently overexpressing 3×Flag-tagged PRMT 8 were lysed, and the overexpressed proteins were purified using Anti-FLAG M2 9 Magnetic Beads. In vitro methylation assay was carried out according to respectively. For each peptide, the sum of the peak areas from the TIC values 20 of the modified peptides was divided by the peak area of the reference 21 unmodified peptide and this value was used as a relative index of the 22 33 methylation and dimethylation. 1 2 Generation of stable cell lines 3 Production of lentivirus was carried out according to Addgene pLKO.1 4 protocol. Scramble shRNA and PRMT shRNA sequences were listed in Table   5 S3. Lentiviruses were packaged by transfection of three plasmids (pLKO.1, 6 psPAX2, and pMD2.G.) into HEK293T cells, and the stably transfected cells 7 were selected with puromycin for at least two weeks. The knockdown PE150 sequencing model. 17 18 Immunoprecipitation and substrate validation 19 The lysate of HEK293T cells was separated into trisection and incubated PRMTs were also detected via western blot (antibodies listed in Table S3 ). 14 15 RNA-seq of polysome profiling fractions 16 mRNAs from indicated fractions of polysome profiling samples were 17 extracted with TriZol reagent. RNA-seq libraries were prepared by 18 NEBNext®EUltra™ II Directional RNA Library Prep Kit for Illumina (NEB) and 19 subjected to deep sequencing with Illumina Hiseq X10 under PE150 20 sequencing model. 21 22 Measurement of global protein synthesis by puromycin incorporation 1 HEK293T, HCT116 and U2OS cells were incubated with specific inhibitors 2 (see Table S3 ) against several PRMTs. Subsequently, puromycin Cleared cell lysates from polysome profiling procedure were treated with 10 RNase I to obtain ribosome-protected mRNA fragments (RPF). Subsequently, 11 lysates were loaded onto 10-50% sucrose gradients, ultracentrifuged and with some modifications. The RPF library was prepared as described in 16 Illumina Small RNA Library Prep Reference Guide. RNA samples were Acknowledgements 13 We thank Han Yan at Omics Core of Bio-Med Big Data Center, CAS-MPG 14 Partner Institute for Computational Biology (PICB), for assistance with 15 next-generation sequencing. We also thank Yu-Jie Chen at Uli Schwarz 16 Quantitative Biology Core Facility, PICB, for experimental support with this Antibodies and other resources used in this study were listed in Table S3 . 13 Competing interests 14 The authors declare that they have no competing interests. 
